Hospital

The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.

Gilead Sciences' remdesivir is the first drug to receive FDA approval for treating COVID-19 in the United States.

Study shows that more than half of older patients hospitalized for heart failure are discharged with 10 or more prescriptions, putting them at significant risk for harm related to high medication burden.

The trial’s main goal is to compare the health status of participants in the combination treatment group with participants in the remdesivir-only group on day 7.

Sirolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection.

Evidence-based cancer regimens have been shown to result in better outcomes, including longer survival and less toxicity.

Heart attack, stroke, stent placement, or heart failure hospitalization occurred in 5.3% of the telemonitored group compared with 10.4% of the routine primary care group.

Researchers found that the children of women with preeclampsia had higher systolic blood pressure on average.

Although earlier research has shown slight reductions in opioid abuse rates, this analysis is the first to show statistically significant year-to-year declines.

This yearlong campaign recognizes pharmacists for their dedication, and often overlooked contributions, to transforming health care.

To celebrate American Pharmacists Month, Pharmacy Times spoke with several pharmacists about their experiences during the COVID-19 pandemic and how they have tackled its unique challenges.

In pharmacy management, a ‘one-size-fits-all’ approach might not be the most appropriate for providing performance feedback during formal review sessions.

It is especially important to better understand the interactions between COVID-19 and acute respiratory distress syndrome.

This week’s pharmacy management Tip of the Week takes a look at establishing a clinical pharmacy site in the emergency department (ED) of a hospital.

There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

The action is part of a growing movement to expand the ability of pharmacists and pharmacy staff to meet the needs of patients during the COVID-19 pandemic.

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.

Although the adverse effects of the lockdown were inevitable for cardiology patients, increased technology services may offer an opportunity for expanded patient access.

With election season intensifying, 35% of voters said drug pricing is among the most important issues influencing their vote in November.

Although researchers are testing modifications of a drug used to cure a fatal coronavirus found in cats, it shows enough action against SARS-CoV-2 to proceed to clinical trials.

Despite an ongoing long-term debate, no link was found between cancer and the use of ACE inhibitors, beta blockers, and other common antihypertensive drugs.

Millions of Americans have vision impairments and ensuring their access to websites is not only important for their health but is also a good business practice.

Investigators found that approximately 36% of the patients studied received a dosage strength of 250 mg of morphine over a 5-day period, above the CDC’s threshold for risky opioid prescribing.

A patient is experiencing severe brain fog, difficulty speaking, bilateral muscle weakness, and ataxia.

Although a study suggests that patients may show a clinical improvement when receiving a 5-day course of remdesivir, investigators said this is of uncertain clinical significance.

The US government will purchase 150 million of the new rapid COVID-19 tests in a $750 million deal with Abbott Laboratories, according to CNBC.

Although dementia-related deaths appear to be underreported overall, a study showed especially striking discrepancies for Black, male, and less educated older adults.

In an analysis, participants ages 56 and older produced neutralizing antibodies higher than those seen among patients who have recovered from COVID-19.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.